Get the Stockscreener App
5.19
4.22%
0.21
Vanda Pharmaceuticals Inc Stock (VNDA) Forecast
The Vanda Pharmaceuticals Inc (VNDA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.5211, representing a +6.38% increase from the current price of $5.19. The highest analyst price target is $7.1221, and the lowest is $3.9201.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VNDA Price Target
Average 3.6926
(-28.85% Downside)
Is Vanda Pharmaceuticals Inc (VNDA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.12 | Neutral |
| STOCH(9,6) | 30.46 | Neutral |
| STOCHRSI(14) | 43.54 | Neutral |
| MACD(12,26) | 0.0669 | Sell |
| ADX(14) | 25.17 | Buy |
| William %R | -48.97 | Neutral |
| CCI(14) | 41.90 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.015
Buy
|
5.0477
Buy
|
| MA20 |
5.02
Buy
|
4.998
Buy
|
| MA50 |
4.8059
Buy
|
4.9525
Buy
|
| MA100 |
5.1344
Buy
|
4.9995
Buy
|
| MA200 |
4.9911
Buy
|
4.9741
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, VNDA could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on VNDA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.12 indicates that VNDA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.46 indicates that VNDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 43.54 indicates that VNDA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.17 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 41.9 indicates that VNDA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VNDA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vanda Pharmaceuticals Inc financial reports and earnings history, Vanda Pharmaceuticals Inc (VNDA) stock could reach $7.3866 by 2030, $8.8034 by 2040 and $23.20 by 2050. See the projected annual prices until 2050 of the Vanda Pharmaceuticals Inc stock below:
- Vanda Pharmaceuticals Inc (VNDA) is expected to reach an average price of $4.6967 in 2035, with a high prediction of $4.5817 and a low estimate of $4.1107. This indicates an $-9.51% rise from the last recorded price of $5.19.
- Vanda Pharmaceuticals Inc (VNDA) stock is projected to chart a bullish course in 2040, with an average price target of $9.0334, representing an $74.05% surge from its current level. The forecast ranges from a conservative $8.8044 to a sky-high $8.8034.
- Our analysts predict Vanda Pharmaceuticals Inc (VNDA) to jump 169.17% by 2045, soaring from $14.04 to an average price of $13.97, potentially reaching $14.04. While $14.04 is the low estimate, the potential upside is significant.
- Vanda Pharmaceuticals Inc (VNDA) stock is expected to climb by 2050, reaching an average of $22.28, a $329.29% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.20 and $23.33, respectively, highlighting the market's uncertainty.
Vanda Pharmaceuticals Inc Stock (VNDA) Year by Year Forecast
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2024
Our forecast for VNDA stock price in 2024 now indicates an average price target of $3.9289 with a high forecast of $7.1221 and a low forecast of $0.7357. The average prediction reflects an decrease of -24.30% from the last recorded price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $6.9921 | $3.9201 | $7.1221 | +34.72% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2025
Vanda Pharmaceuticals Inc Stock (VNDA) is expected to reach an average price of $3.6926 in 2025, with a high prediction of $7.3695 and a low estimate of $0.0157. This indicates an -28.85% fall from the last recorded price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.6288 | $5.4388 | $7.3695 | +8.45% |
| February, 2025 | $2.5082 | $2.3432 | $6.6261 | -51.67% |
| March, 2025 | $0.6375 | $0.0425 | $3.4702 | -87.72% |
| April, 2025 | $0.0592 | $0.2152 | $1.4422 | -98.86% |
| May, 2025 | $1.7935 | $0.4285 | $2.1035 | -65.44% |
| June, 2025 | $1.6729 | $0.7586 | $2.4609 | -67.77% |
| July, 2025 | $1.5946 | $0.5722 | $2.3702 | -69.28% |
| August, 2025 | $1.9489 | $1.3142 | $2.5316 | -62.45% |
| September, 2025 | $2.5683 | $0.4409 | $2.8163 | -50.52% |
| October, 2025 | $0.965 | $0.505 | $3.1129 | -81.41% |
| November, 2025 | $0.4743 | $0.0157 | $0.9023 | -90.86% |
| December, 2025 | $1.661 | $0.4616 | $2.251 | -68.00% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2026
The predicted value for Vanda Pharmaceuticals Inc (VNDA) in 2026 is set at an average of $7.7854. Estimates vary from a peak of $13.85 to a trough of $1.7183, indicating an +50.01% surge from the present price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.4703 | $1.7183 | $4.493 | -33.13% |
| February, 2026 | $4.9697 | $3.1677 | $5.0797 | -4.24% |
| March, 2026 | $5.009 | $4.0232 | $5.679 | -3.49% |
| April, 2026 | $10.12 | $4.9664 | $11.60 | +94.91% |
| May, 2026 | $8.9951 | $8.4951 | $11.95 | +73.32% |
| June, 2026 | $7.8844 | $6.0897 | $9.4524 | +51.92% |
| July, 2026 | $10.42 | $7.4018 | $10.43 | +100.79% |
| August, 2026 | $11.06 | $9.3481 | $11.24 | +113.11% |
| September, 2026 | $12.54 | $10.40 | $13.85 | +141.56% |
| October, 2026 | $8.1465 | $7.6465 | $12.74 | +56.97% |
| November, 2026 | $8.9758 | $7.3159 | $9.6058 | +72.94% |
| December, 2026 | $9.5225 | $8.1305 | $10.16 | +83.48% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vanda Pharmaceuticals Inc (VNDA) is $8.2865, with a high forecast of $13.98 and a low forecast of $2.5967. This indicates an +59.66% increase from the last price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.81 | $9.2899 | $11.27 | +108.32% |
| February, 2027 | $9.5512 | $9.4912 | $13.98 | +84.03% |
| March, 2027 | $9.4279 | $8.2606 | $10.42 | +81.66% |
| April, 2027 | $7.8372 | $6.9972 | $10.76 | +51.01% |
| May, 2027 | $4.9766 | $4.1466 | $8.1566 | -4.11% |
| June, 2027 | $3.9233 | $3.6286 | $7.1513 | -24.41% |
| July, 2027 | $4.5026 | $3.8506 | $5.5326 | -13.24% |
| August, 2027 | $4.242 | $4.092 | $5.3346 | -18.27% |
| September, 2027 | $3.6587 | $2.5967 | $4.3193 | -29.51% |
| October, 2027 | $3.118 | $2.788 | $4.0107 | -39.92% |
| November, 2027 | $5.4174 | $3.2754 | $5.5574 | +4.38% |
| December, 2027 | $4.204 | $3.7767 | $5.5247 | -19.00% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2028
In 2028, Vanda Pharmaceuticals Inc (VNDA) is projected to reach an average price of $3.0514, with a high projection of $5.3833 and a low estimate of $0.7195. This indicates an -41.21% fall from the last price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.2834 | $3.8714 | $4.9261 | -17.47% |
| February, 2028 | $3.8927 | $3.3477 | $4.3707 | -25.00% |
| March, 2028 | $4.6194 | $3.5674 | $4.8094 | -10.99% |
| April, 2028 | $4.6888 | $3.7768 | $5.1041 | -9.66% |
| May, 2028 | $1.2655 | $1.0981 | $5.3833 | -75.62% |
| June, 2028 | $2.0448 | $1.1628 | $2.4975 | -60.60% |
| July, 2028 | $1.8842 | $1.7342 | $2.7641 | -63.70% |
| August, 2028 | $0.9508 | $0.8058 | $1.9815 | -81.68% |
| September, 2028 | $1.7302 | $0.9082 | $1.7902 | -66.66% |
| October, 2028 | $1.9195 | $0.7195 | $1.9695 | -63.01% |
| November, 2028 | $1.1662 | $0.9689 | $1.9769 | -77.53% |
| December, 2028 | $1.8056 | $1.0486 | $1.9756 | -65.21% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2029
The 2029 price forecast for Vanda Pharmaceuticals Inc Stock (VNDA) is $3.1528 on average, with a high prediction of $6.26 and a low estimate of $0.0457. This represents an -39.25% decrease from the previous price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1323 | $0.9323 | $2.0349 | -78.18% |
| February, 2029 | $1.0416 | $0.8296 | $1.5719 | -79.93% |
| March, 2029 | $0.271 | $0.141 | $1.1189 | -94.78% |
| April, 2029 | $0.0697 | $0.1247 | $0.3583 | -98.66% |
| May, 2029 | $0.773 | $0.0477 | $0.4147 | -85.11% |
| June, 2029 | $0.1737 | $0.4237 | $0.4533 | -96.65% |
| July, 2029 | $0.2557 | $0.0457 | $0.4367 | -95.07% |
| August, 2029 | $0.2276 | $0.143 | $0.658 | -95.61% |
| September, 2029 | $0.7317 | $0.1903 | $0.9017 | -85.90% |
| October, 2029 | $0.3084 | $0.1284 | $1.0691 | -94.06% |
| November, 2029 | $1.6378 | $0.3007 | $2.5031 | -68.44% |
| December, 2029 | $6.63 | $0.9851 | $6.26 | +27.75% |
Vanda Pharmaceuticals Inc Stock (VNDA) Price Forecast for 2030
Vanda Pharmaceuticals Inc Stock (VNDA) is expected to reach an average price of $7.169 in 2030, with a high forecast of $10.09 and a low forecast of $4.2517. This signifies an +38.13% surge from the last price of $5.19.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.9116 | $7.3203 | $7.3866 | +52.44% |
| February, 2030 | $8.6279 | $8.5998 | $8.3379 | +66.24% |
| March, 2030 | $6.8892 | $7.3392 | $9.1639 | +32.74% |
| April, 2030 | $7.8405 | $7.4646 | $7.0005 | +51.07% |
| May, 2030 | $8.3272 | $8.1809 | $7.9772 | +60.45% |
| June, 2030 | $7.3835 | $7.9085 | $8.0378 | +42.26% |
| July, 2030 | $4.9301 | $5.9451 | $7.2891 | -5.01% |
| August, 2030 | $4.2464 | $4.2958 | $3.9104 | -18.18% |
| September, 2030 | $4.5977 | $4.2517 | $4.1224 | -11.41% |
| October, 2030 | $7.5943 | $6.163 | $6.8643 | +46.33% |
| November, 2030 | $10.33 | $8.3347 | $8.7203 | +98.95% |
| December, 2030 | $9.7769 | $10.41 | $10.09 | +88.38% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):